Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin

Infection and Immunity

Volumn 64, Issue 4, 1996, Pages 1437-1440

  Kincy Cain, Tammy ^a   Clements, John D ^a   Bost, Kenneth L ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MONOCLONAL ANTIBODY; SALMONELLOSIS VACCINE;

ANIMAL MODEL; ARTICLE; BIOASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA DUBLIN; SALMONELLOSIS; SURVIVAL TIME;

EID: 0029916338     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.4.1437-1440.1996     Document Type: Article

References (30)

1. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott, 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania majoi. Science 263:235-237.
2. Biron, C. A., and R. T. Gazzinelli. 1995 Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease out-come. Curr. Opin Immunol 7:485-496.
3. Bost, K. L., and J. D. Clements. 1995 In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun 63:1076-1083.
4. Chong, C., K. L. Bost, and J. D. Clements. 1996. Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect. Immun. 64:1154-1160.
5. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of IL-12 in acquired immunity to Mycobacterium tuberculosis infection Immunology 84:423-432.
6. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995 IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection J. Immunol. 155:2515-2524.
7. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. IL-12 is required for the T-lymphocyte-independent induction of interferon-gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts Proc. Natl. Acad Sci USA 90:6115-6119.
8. Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn. P. C. Familletti, and M. K. Gately. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl. Acad. Sci USA 88:4143-4147.
9. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant IL-12 cures mice infected with Letshmama major. J. Exp. Med. 177:1505-1509.
10. Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
11. Hsu, H. S. 1989. Pathogenesis and immunity in murine salmonellosis. Microbiol. Rev. 53:390-409.
12. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of gamma Interferon by natural killer cells from Taxoplasma gondit-infected SCID mice. Infect Immun. 62:2818-2824.
13. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. IL-12 enhances murine survival against acute toxoplasmosis. Infect. Immun 62:1639-1642.
14. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. London, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes J. Exp. Med. 170:827-845
15. Manetti, R., F. Gerosa, M. G. Giudizi, R. Biagiotti, P. Parronchi, M.-P. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani, and G. Trinchieri. 1994. IL-12 induces stable priming for interferon gamma production during differentiation of human T helper (Th) cells and transient interferon-gamma production in established Th2 cell clones. J. Exp. Med 179:1273-1283.
16. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing cells. J. Exp. Med. 177: 1199-1204
17. Mattner, R., S. Fischer, S. Guckes, S. Jin, H. Kaulen, E. Schmitt, E. Rude, and T. Germann. 1993. The p40 subunit of IL-12 inhibits bioactivity of the IL-12 heterodimer. Eur. J. Immunol. 23:2202-2208.
18. Murray, H. W., and J. Hariprashad. 1995. Interleukin-12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387-391.
19. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152: 1253-1264.
20. Ramarathinam, L., D. W. Neisel, and G. R. Klimpel. 1993. Salmonella typhimurium induces interferon-gamma production in murine splenocytes J. Immunol 150:3973-3981.
21. Schijns, V. E. C. J., B. L. Haagmans, and M. C. Horzinek. 1995. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in interferon gamma receptor deficient mice. J. Immunol 155:2525-2532
22. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496-497.
23. Seder, R. A., R. Gazzinelli, A. Sher, and W. E. Paul. 1993 IL-12 acts directly on CD4+ T cells to enhance priming for gamma-interferon production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90: 10188-10192.
24. Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y. E. Pan, P. M. Quinn, A. G. Wolitsky, C. Familletti, D. L. Stremlo, T. Truitt, R. Chizzonite, and M. K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808-6812.
25. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993 Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
26. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listena in SCID and C.B-17 mice. Reversal by gamma-interferon. J. Immunol. 152:1883-1887
27. Vieira, L. Q., B. D. Hondowicz, L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1994 Infection with Leishmania major induces interleukin-12 production in vivo. Immunol. Lett. 40:157-161.
28. Wolf, S. F., P. A. Temple, M. Kobayashe, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146: 3074-3081
29. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672-676.
30. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387-1390.